Patrick Crutcher
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Patrick Crutcher
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Patrick Crutcher tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ELIEM THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Stephen Thomas | 5 |
- Borsa valori
- Insiders
- Patrick Crutcher
- Connessioni Società
